Commentary: Hybrid Ablation of Atrial Fibrillation-A Grass Roots Campaign
Semin Thorac Cardiovasc Surg
.
2023 Summer;35(2):287-288.
doi: 10.1053/j.semtcvs.2022.03.008.
Epub 2022 Apr 2.
Authors
Marc Gillinov
1
,
Kevin Hodges
2
,
Edward G Soltesz
2
Affiliations
1
Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio. Electronic address: gillinom@ccf.org.
2
Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio.
PMID:
35381351
DOI:
10.1053/j.semtcvs.2022.03.008
No abstract available
Publication types
Editorial
MeSH terms
Anti-Arrhythmia Agents / therapeutic use
Atrial Fibrillation* / diagnosis
Atrial Fibrillation* / surgery
Catheter Ablation* / adverse effects
Humans
Recurrence
Treatment Outcome
Substances
Anti-Arrhythmia Agents